THE ROLE OF AUTOHEMOTHERAPY WITH OZONE AS AN EFFECTIVE TREATMENT FOR FIBROMYALGIA

This book examines the role of major autohemotherapy with ozone as a therapeutic intervention for fibromyalgia, a chronic pain condition affecting two to four percent of the general population and one that existing pharmacological and non-pharmacological treatments consistently fail to address adequately. The central argument is that ozone therapy, unlike conventional approaches that focus on single symptom pathways, acts on several of the main biological abnormalities involved in fibromyalgia at the same time, including oxidative stress, inflammatory imbalance, mitochondrial dysfunction, impaired peripheral oxygen delivery and autonomic dysregulation. After reviewing the pathophysiology of fibromyalgia and the limitations of current treatment approaches, the book presents the science and mechanisms of medical ozone, the major autohemotherapy procedure and the broader clinical evidence for ozone therapy in chronic musculoskeletal pain. The central chapter presents the author's prospective clinical study, conducted in twenty fibromyalgia patients who received ten sessions of major ozone autohemotherapy at concentrations of 30 to 60 micrograms per milliliter over five weeks.